call Toll Free (US/Canada): +1 866 658 6826 | call+1 425 320 4776 | call (UK): +44 1865 60 0662 | call (Ind): +91 9096278110 | email info(@)blueweaveconsulting.com
Home | About Us | Career | Services | Blog | Contact Us
Blueweave
Europe Antibiotics Market
Inquire Before Buying Request for Sample

Europe Antibiotics Market

Home Healthcare And Pharmaceutical Europe Antibiotics Market

Europe Antibiotics Market, By Drug Class (Cephalosporin, Penicillin, Fluoroquinolone, Macrolides, Carbapenems, Aminoglycosides, Sulfonamides, 7-ACA, Others); By Type (Branded Antibiotics, Generic Antibiotics); By Action Mechanism (Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, Mycolic Acid Inhibitors, Others); By Country (Germany, United Kingdom, Italy, France, Spain, Belgium, Russia, The Netherlands, Rest of Europe), Trend Analysis, Competitive Landscape & Forecast, 2019–2030

  • Published Date: December 2024
  • Report ID: BWC24938
  • Available Format: PDF
  • Page: 260

Report Overview

The rising prevalence of infectious diseases, growing aging population, and increased awareness and diagnosis rates are expected to drive Europe Antibiotics Market during the forecast period between 2024 and 2030

Europe Antibiotics Market – Industry Trends & Forecast Report, 2030

Europe Antibiotics Market size was estimated at USD 12 billion in 2023. During the forecast period between 2024 and 2030, Europe Antibiotics Market size is projected to grow at a CAGR of 2.8% reaching a value of USD 14.4 billion by 2030. Prominent drivers of the market include the rising incidence of infectious diseases, such as the 4,500 cases of hepatitis A reported in Europe in 2022, as well as the 65,000 annual deaths due to bacterial infections resistant to antimicrobials. The expansion of developed antibiotic products, coupled with growing partnerships for introducing new antibiotics, is also driving market growth. Major pharmaceutical companies, including AbbVie, Inc., Pfizer Inc., and Merck & Co. Inc., are investing heavily in research and development. Additionally, the prevalence of Chronic Obstructive Pulmonary Disease (COPD), which affected over 36 million people in Europe in 2020, is further contributing to the demand for antibiotics. The ongoing development of innovative treatments and clinical trials for infectious diseases, along with efforts to combat antimicrobial resistance, also support the market's expansion. Moreover, the COVID-19 pandemic led to a surge in antibiotic use, particularly in the treatment of bacterial infections in COVID-19 patients, creating growth opportunities for the Europe Antibiotics Market.

Europe Antibiotics Market

Antibiotics – Overview

Antibiotics are drugs that help treat bacterial infections in both humans and animals. They work by either eliminating bacteria or preventing their growth and reproduction. These medications are commonly used to treat a variety of conditions, such as strep throat, urinary tract infections, sinus infections, pneumonia, skin infections, ear infections, and more. Antibiotics can be classified in several ways, with the most widely used methods being based on their chemical composition, effectiveness against different bacteria, and their specific mode of action. At present, there is an increased demand for antibiotics from the beta-lactam and beta-lactamase inhibitor classes.

Europe Antibiotics Market

Growth Drivers

Rising Prevalence of Infectious Diseases

The rising prevalence of infectious diseases and the growing threat of antimicrobial resistance (AMR) are driving significant growth in Europe Antibiotics Market. Antimicrobial resistance, where microorganisms evolve to resist treatments, particularly antibiotics, has become a critical public health issue across Europe. Infections caused by resistant bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA), are increasingly difficult to treat, leading to a heightened demand for effective antibiotics. The misuse and overuse of antibiotics accelerate the development of resistant strains, exacerbating the issue. As resistance continues to spread, the need for novel antimicrobial medicines, alternatives, and rapid diagnostics becomes even more urgent. This growing challenge is pushing for accelerated efforts in the development and responsible use of antibiotics, stimulating the market's expansion as healthcare systems strive to combat the rising tide of resistant infections. Furthermore, initiatives like European Antibiotic Awareness Day and the European Medicines Agency's (EMA) support for the development of new medicines underline the importance of addressing AMR to safeguard public health and ensure the continued efficacy of antibiotics in treating infectious diseases.

Challenges

Rise of Multi-Drug Resistant (MDR) Bacteria

The rise of multi-drug-resistant (MDR) bacteria is a major restraint on the growth of Europe Antibiotics Market. The resistant strains, which no longer respond to conventional antibiotics, complicate treatment options and increase healthcare costs. The lack of new antibiotics entering the market further exacerbates the situation, as existing drugs become less effective against evolving pathogens. The spread of MDR bacteria not only threatens public health but also challenges healthcare systems to manage infections effectively, leading to an increased demand for alternative treatments and diagnostic solutions, which limits the market's growth potential.

Impact of Escalating Geopolitical Tensions on Europe Antibiotics Market

Escalating geopolitical tensions among countries, particularly prolonging Russia-Ukraine war, and further spreading across the region could have a significant impact on the growth of Europe Antibiotics Market. Political, economic, and trade tensions and sanctions could disrupt global supply chains, particularly affecting the import of raw materials and active pharmaceutical ingredients (APIs) from key producers in major APAC countries like China and India. Trade restrictions and political instabilities may lead to shortages and delays in antibiotic production, driving up costs. Additionally, the uncertainties surrounding geopolitical relations could hinder international collaborations in research and development, slowing the pace of innovations in new antibiotics. It may lead to limited access to essential antibiotics, thereby restricting market growth and heightening the threat of antimicrobial resistance.

Europe Antibiotics Market

Segmental Coverage

Europe Antibiotics Market – By Drug Class

Based on drug class, Europe Antibiotics Market is divided into Cephalosporin, Penicillin, Fluoroquinolone, Macrolides, Carbapenems, Aminoglycosides, Sulfonamides, 7-ACA, and other segments. The penicillin segment holds the largest share of Europe Antibiotics Market by drug class. Penicillin remains a primary treatment option for various bacterial infections, particularly those caused by streptococci, staphylococci, listeria, and clostridium. The segment works by inhibiting cell wall synthesis or preventing the formation of the peptidoglycan layer, making it effective in treating conditions such as skin infections, pharyngitis, gonorrhea, ear infections, and bronchitis. As the first line of defense, penicillin is widely prescribed. According to the 2021 ECDA study, Europe’s average usage ratio of broad-spectrum penicillin, cephalosporins, macrolides, and fluoroquinolones to narrow-spectrum penicillin, cephalosporins, and erythromycin was over 3.5.

Europe Antibiotics Market – By Type

Europe Antibiotics Market by type is bifurcated into Branded Antibiotics and Generic Antibiotics segments. The genetic antibiotics segment holds a higher share in Europe Antibiotics Market by type, due to their affordability, the presence of numerous manufacturers that increase buyer bargaining power, and a supportive regulatory environment. Additionally, policies promoting the use of generic formulations and facilitating easy access to these drugs drive the segment's growth. Regulatory initiatives focused on ensuring safety and efficacy also contribute to the expansion of the market. For example, in June 2022, Venus Remedies received approval from Venus Pharma, its German subsidiary, to sell 2g, 1g, and 500mg antibiotic injections in Spain, further strengthening its presence in the European market.

Europe Antibiotics Market Size

Europe Antibiotics Market – By Action Mechanism

On the basis of action mechanism, Europe Antibiotics Market is divided into Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, Mycolic Acid Inhibitors, and other segments. The cell wall synthesis inhibitors segment holds the largest share of Europe Antibiotics Market by action of mechanism. Cell wall synthesis inhibitors are commonly used antibiotics with broad-spectrum activity against both gram-negative and gram-positive bacteria. These drugs function by blocking the formation of the peptidoglycan layer, which is crucial for maintaining the structural integrity of the bacterial cell wall. The segment is expected to experience significant growth in the coming years, fueled by enhanced research initiatives and government funding in the field.

Europe Antibiotics Market – By Country

The in-depth research report on Europe Antibiotics Market covers the market in the region’s major countries including Germany, United Kingdom, Italy, France, Spain, Belgium, Russia, The Netherlands, and Rest of Europe. France holds the highest share in Europe Antibiotics Market and is expected to maintain dominance during the forecast period. It is primarily driven by the high demand for outpatient prescriptions. Despite ongoing efforts to combat antimicrobial resistance, antibiotic usage remains elevated in outpatient settings. A 2022 study by the National Center for Biotechnology Information (NCBI) revealed that in 2019, France ranked as the fourth-largest consumer of antibiotics in outpatient settings, with more than 23.0 defined daily doses (DDD) per 1,000 people daily, surpassing the European average by over 25%. Meanwhile, United Kingdom is expected to record the fastest growth rate during the forecast period. It can be primarily due to the high incidence of pneumonia. According to a Medscape UK study published in November 2022, pneumonia causes more deaths in the UK than in any other European country, with over 40,000 fatalities annually. The prevalence of pneumonia and other respiratory infections is therefore a key driver of growth in the United Kingdom Antibiotics Market.

Europe Antibiotics Market Share

Competitive Landscape

Major companies operating in Europe Antibiotics Market include Novartis, GlaxoSmithKline (GSK), Pfizer, Bayer, Sanofi, Roche, Teva Pharmaceutical Industries, Stada Arzneimittel, Menarini Group, and Recordati. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

  • In December 2023 - Shionogi B.V. entered into a distribution agreement with Swedish Orphan Biovitrum AB (SOBI) to jointly promote and commercialize cefiderocol, with Shionogi B.V. holding the marketing authorization.

  • In November 2023 - Sandoz launched a new penicillin production plant in Kundl, Austria.

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2019–2030

Base Year – 2023

Estimated Year – 2024

Forecast Period – 2024–2030

Facts Covered

Revenue in USD Billion

Market Coverage

Germany, United Kingdom, Italy, France, Spain, Belgium, Russia, The Netherlands, Rest of Europe

Product/ Service Segmentation

Drug Class, Type, Action Mechanism, Country

Key Players

Novartis, GlaxoSmithKline (GSK), Pfizer, Bayer, Sanofi, Roche, Teva Pharmaceutical Industries, Stada Arzneimittel, Menarini Group, Recordati

 

By Drug Class

  • Cephalosporin

  • Penicillin

  • Fluoroquinolone

  • Macrolides

  • Carbapenems

  • Aminoglycosides

  • Sulfonamides

  • 7-ACA

  • Others

By Type

  • Branded Antibiotics

  • Generic Antibiotics

By Action Mechanism

  • Cell Wall Synthesis Inhibitors

  • Protein Synthesis Inhibitors

  • DNA Synthesis Inhibitors

  • RNA Synthesis Inhibitors

  • Mycolic Acid Inhibitors

  • Others

By Country

  • Germany

  • United Kingdom

  • Italy

  • France

  • Spain

  • Belgium

  • Russia

  • The Netherlands

  • Rest of Europe

  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Executive Summary
  3. Europe Antibiotics Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. Rising prevalence of infectious diseases
        2. Growing aging population
        3. Increased awareness and diagnosis rates
      2. Restraints
        1. Rise of multi-drug-resistant bacteria
        2. Strict EU regulations on antibiotic development and commercialization
        3. Overuse and misuse of antibiotics
      3. Opportunities
        1. Growing investments in antimicrobial resistance (AMR) research
        2. Advancements in sustained-release formulations and targeted therapies
        3. Advancements in antibiotics development
      4. Challenges
        1. High R&D costs
        2. Public health campaigns
    3. Technological Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4. Europe Antibiotics Market: Marketing Strategies
  5. Europe Antibiotics Market Overview
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Drug Class
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenems
        6. Aminoglycosides
        7. Sulfonamides
        8. 7-ACA
        9. Others
      2. By Type
        1. Branded Antibiotics
        2. Generic Antibiotics
      3. By Action Mechanism
        1. Cell Wall Synthesis Inhibitors
        2. Protein Synthesis Inhibitors
        3. DNA Synthesis Inhibitors
        4. RNA Synthesis Inhibitors
        5. Mycolic Acid Inhibitors
        6. Others
      4. By Country
        1. Germany
        2. United Kingdom
        3. Italy
        4. France
        5. Spain
        6. Belgium
        7. Russia
        8. The Netherlands
        9. Rest of Europe
  6. Germany Antibiotics Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Drug Class
      2. By Type
      3. By Action Mechanism
  7. United Kingdom Antibiotics Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Drug Class
      2. By Type
      3. By Action Mechanism
  8. Italy Antibiotics Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Drug Class
      2. By Type
      3. By Action Mechanism
  9. France Antibiotics Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Drug Class
      2. By Type
      3. By Action Mechanism
  10. Spain Antibiotics Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Drug Class
      2. By Type
      3. By Action Mechanism
  11. Belgium Antibiotics Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Drug Class
      2. By Type
      3. By Action Mechanism
  12. Russia Antibiotics Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Drug Class
      2. By Type
      3. By Action Mechanism
  13. The Netherlands Antibiotics Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Drug Class
      2. By Type
      3. By Action Mechanism
  14. Rest of Europe Antibiotics Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Drug Class
      2. By Type
      3. By Action Mechanism
  15. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Europe Antibiotics Company Market Share Analysis, 2023
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships)
  16. Impact of Escalating Geopolitical Tensions on Europe Antibiotics Market
  17. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
    1. Novartis
    2. GlaxoSmithKline (GSK)
    3. Pfizer
    4. Bayer
    5. Sanofi
    6. Roche
    7. Teva Pharmaceutical Industries
    8. Stada Arzneimittel
    9. Menarini Group
    10. Recordati
    11. Other Prominent Players
  18. Key Strategic Recommendations
  19. Research Methodology
    1.       Qualitative Research
      1.   Primary & Secondary Research
    2.       Quantitative Research
    3.       Market Breakdown & Data Triangulation
      1.   Secondary Research
      2.   Primary Research
    4.       Breakdown of Primary Research Respondents, By Country
    5.       Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

          

 

List of Figures

 

Figure 1       Europe Antibiotics Segmentation

Figure 2       Europe Antibiotics Market Value Chain Analysis

Figure 3       Company Market Share Analysis, 2023

Figure 4       Europe Antibiotics Market Size, By Value (USD Billion), 2019–2030

Figure 5       Europe Antibiotics Market Share, By Drug Class, By Value, 2019–2030

Figure 6       Europe Antibiotics Market Share, By Type, By Value, 2019–2030

Figure 7       Europe Antibiotics Market Share, By Action Mechanism, By Value, 2019–2030

Figure 8       Europe Antibiotics Market Share, By Country, By Value, 2019–2030

Figure 9       Germany Antibiotics Market Size, By Value (USD Billion), 2019–2030

Figure 10     Germany Antibiotics Market Share, By Drug Class, By Value, 2019–2030

Figure 11     Germany Antibiotics Market Share, By Type, By Value, 2019–2030

Figure 12     Germany Antibiotics Market Share, By Action Mechanism, By Value, 2019–2030

Figure 13     United Kingdom Antibiotics Market Size, By Value (USD Billion), 2019–2030

Figure 14     United Kingdom Antibiotics Market Share, By Drug Class, By Value, 2019–2030

Figure 15     United Kingdom Antibiotics Market Share, By Type, By Value, 2019–2030

Figure 16     United Kingdom Antibiotics Market Share, By Action Mechanism, By Value, 2019–2030

Figure 17     Italy Antibiotics Market Size, By Value (USD Billion), 2019–2030

Figure 18     Italy Antibiotics Market Share, By Drug Class, By Value, 2019–2030

Figure 19     Italy Antibiotics Market Share, By Type, By Value, 2019–2030

Figure 20     Italy Antibiotics Market Share, By Action Mechanism, By Value, 2019–2030

Figure 21     France Antibiotics Market Size, By Value (USD Billion), 2019–2030

Figure 22     France Antibiotics Market Share, By Drug Class, By Value, 2019–2030

Figure 23     France Antibiotics Market Share, By Type, By Value, 2019–2030

Figure 24     France Antibiotics Market Share, By Action Mechanism, By Value, 2019–2030

Figure 25     Spain Antibiotics Market Size, By Value (USD Billion), 2019–2030

Figure 26     Spain Antibiotics Market Share, By Drug Class, By Value, 2019–2030

Figure 27     Spain Antibiotics Market Share, By Type, By Value, 2019–2030

Figure 28     Spain Antibiotics Market Share, By Action Mechanism, By Value, 2019–2030

Figure 29     Belgium Antibiotics Market Size, By Value (USD Billion), 2019–2030

Figure 30     Belgium Antibiotics Market Share, By Drug Class, By Value, 2019–2030

Figure 31     Belgium Antibiotics Market Share, By Type, By Value, 2019–2030

Figure 32     Belgium Antibiotics Market Share, By Action Mechanism, By Value, 2019–2030

Figure 33     Russia Antibiotics Market Size, By Value (USD Billion), 2019–2030

Figure 34     Russia Antibiotics Market Share, By Drug Class, By Value, 2019–2030

Figure 35     Russia Antibiotics Market Share, By Type, By Value, 2019–2030

Figure 36     Russia Antibiotics Market Share, By Action Mechanism, By Value, 2019–2030

Figure 37     The Netherlands Antibiotics Market Size, By Value (USD Billion), 2019–2030

Figure 38     The Netherlands Antibiotics Market Share, By Drug Class, By Value, 2019–2030

Figure 39     The Netherlands Antibiotics Market Share, By Type, By Value, 2019–2030

Figure 40     The Netherlands Antibiotics Market Share, By Action Mechanism, By Value, 2019–2030

Figure 41     Rest of Europe Antibiotics Market Size, By Value (USD Billion), 2019–2030

Figure 42     Rest of Europe Antibiotics Market Share, By Drug Class, By Value, 2019–2030

Figure 43     Rest of Europe Antibiotics Market Share, By Type, By Value, 2019–2030

Figure 44     Rest of Europe Antibiotics Market Share, By Action Mechanism, By Value, 2019–2030

 

List of Tables

 

Table 1        Europe Antibiotics Market Size, By Value (USD Billion), 2019–2030

Table 2        Europe Antibiotics Market Size, By Drug Class, By Value, 2019–2030

Table 3        Europe Antibiotics Market Size, By Type, By Value, 2019–2030

Table 4        Europe Antibiotics Market Size, By Action Mechanism, By Value, 2019–2030

Table 5        Europe Antibiotics Market Size, By Country, By Value, 2019–2030

Table 6        Germany Antibiotics Market Size, By Value (USD Billion), 2019–2030

Table 7        Germany Antibiotics Market Size, By Drug Class, By Value, 2019–2030

Table 8        Germany Antibiotics Market Size, By Type, By Value, 2019–2030

Table 9        Germany Antibiotics Market Size, By Action Mechanism, By Value, 2019–2030

Table 10      United Kingdom Antibiotics Market Size, By Value (USD Billion), 2019–2030

Table 11      United Kingdom Antibiotics Market Size, By Drug Class, By Value, 2019–2030

Table 12      United Kingdom Antibiotics Market Size, By Type, By Value, 2019–2030

Table 13      United Kingdom Antibiotics Market Size, By Action Mechanism, By Value, 2019–2030

Table 14      Italy Antibiotics Market Size, By Value (USD Billion), 2019–2030

Table 15      Italy Antibiotics Market Size, By Drug Class, By Value, 2019–2030

Table 16      Italy Antibiotics Market Size, By Type, By Value, 2019–2030

Table 17      Italy Antibiotics Market Size, By Action Mechanism, By Value, 2019–2030

Table 18      France Antibiotics Market Size, By Value (USD Billion), 2019–2030

Table 19      France Antibiotics Market Size, By Drug Class, By Value, 2019–2030

Table 20      France Antibiotics Market Size, By Type, By Value, 2019–2030

Table 21      France Antibiotics Market Size, By Action Mechanism, By Value, 2019–2030

Table 22      Spain Antibiotics Market Size, By Value (USD Billion), 2019–2030

Table 23      Spain Antibiotics Market Size, By Drug Class, By Value, 2019–2030

Table 24      Spain Antibiotics Market Size, By Type, By Value, 2019–2030

Table 25      Spain Antibiotics Market Size, By Action Mechanism, By Value, 2019–2030

Table 26      Belgium Antibiotics Market Size, By Value (USD Billion), 2019–2030

Table 27      Belgium Antibiotics Market Size, By Drug Class, By Value, 2019–2030

Table 28      Belgium Antibiotics Market Size, By Type, By Value, 2019–2030

Table 29      Belgium Antibiotics Market Size, By Action Mechanism, By Value, 2019–2030

Table 30      Russia Antibiotics Market Size, By Value (USD Billion), 2019–2030

Table 31      Russia Antibiotics Market Size, By Drug Class, By Value, 2019–2030

Table 32      Russia Antibiotics Market Size, By Type, By Value, 2019–2030

Table 33      Russia Antibiotics Market Size, By Action Mechanism, By Value, 2019–2030

Table 34      The Netherlands Antibiotics Market Size, By Value (USD Billion), 2019–2030

Table 35      The Netherlands Antibiotics Market Size, By Drug Class, By Value, 2019–2030

Table 36      The Netherlands Antibiotics Market Size, By Type, By Value, 2019–2030

Table 37      The Netherlands Antibiotics Market Size, By Action Mechanism, By Value, 2019–2030

Table 38      Rest of Europe Antibiotics Market Size, By Value (USD Billion), 2019–2030

Table 39      Rest of Europe Antibiotics Market Size, By Drug Class, By Value, 2019–2030

Table 40      Rest of Europe Antibiotics Market Size, By Type, By Value, 2019–2030

Table 41      Rest of Europe Antibiotics Market Size, By Action Mechanism, By Value, 2019–2030

Table 42      Novartis Company Overview

Table 43      Novartis Financial Overview

Table 44      GlaxoSmithKline (GSK) Company Overview

Table 45      GlaxoSmithKline (GSK) Financial Overview

Table 46      Pfizer Company Overview

Table 47      Pfizer Financial Overview

Table 48      Bayer Company Overview

Table 49      Bayer Financial Overview

Table 50      Sanofi Company Overview

Table 51      Sanofi Financial Overview

Table 52      Roche Company Overview

Table 53      Roche Financial Overview

Table 54      Teva Pharmaceutical Industries Company Overview

Table 55      Teva Pharmaceutical Industries Financial Overview

Table 56      Stada Arzneimittel Company Overview

Table 57      Stada Arzneimittel Financial Overview

Table 58      Menarini Group Company Overview

Table 59      Menarini Group Financial Overview

Table 60      Recordati Company Overview

Table 61      Recordati Financial Overview

Market Segmentation

No data available
No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: Europe Antibiotics Market size by value was estimated at USD 12 billion in 2023.
Ans: Europe Antibiotics Market is expected to grow at CAGR of 2.8% period between 2024 and 2030.
Ans: By 2030, Europe Antibiotics Market size is forecast to reach a value of USD 14.4 billion.
Ans: The growth of Europe Antibiotics Market is primarily driven by The rising prevalence of infectious diseases, rapidly aging population, and increased awareness and diagnosis rates.
Ans: France accounts for a major market share in Europe Antibiotics Market.
Ans: The penicillin segment is expected to grow at the fastest CAGR in Europe Antibiotics Market during the forecast period between 2024 and 2030.
Ans: Key players in Europe Antibiotics Market include Novartis, GlaxoSmithKline (GSK), Pfizer, Bayer, Sanofi, Roche, Teva Pharmaceutical Industries, Stada Arzneimittel, Menarini Group, and Recordati.